---
title: "Ind-Swift Laboratories Ltd (INDSWFTLAB) — Share Price, Financials & Analysis"
symbol: "INDSWFTLAB"
company: "Ind-Swift Laboratories Ltd"
canonical: "https://tapetide.com/stocks/INDSWFTLAB"
isin: "INE915B01019"
nse_symbol: "INDSWFTLAB"
bse_code: "532305"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 3284.59
generated_at: "2026-09-13T18:56:26.657Z"
---

# Ind-Swift Laboratories Ltd (INDSWFTLAB)

Canonical page: https://tapetide.com/stocks/INDSWFTLAB

## Company

- **NSE Symbol:** INDSWFTLAB
- **BSE Code:** 532305
- **ISIN:** INE915B01019
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1997-07-02
- **CEO:** Mr. Navrattan R. Munjal
- **Employees:** 1246
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** indswiftlabs.com

## About

Incorporated in 1995, Ind-Swift Laboratories 
Ltd is a pharmaceutical company focused 
on finished dosage formulations (FDF). Co. manufactures tablets, capsules, ointments, injectables, liquids and dry syrups across therapies including gynaecology, paediatrics, cardiology, diabetology and dermatology. Operations span domestic formulations 
and international markets through own 
brands, contract manufacturing and out-licensing.[1]

## Latest Price

- **Price:** ₹385.35
- **Change:** +7.85 (+2.08%)
- **Open:** ₹375
- **Day High:** ₹391.4
- **Day Low:** ₹372.3
- **Previous Close:** ₹377.5
- **Volume:** 565658
- **As Of:** 2026-09-11T10:29:14+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:46.942430Z.

- **Market Cap:** ₹3284.59 Cr
- **Classification:** Microcap
- **P/E (reported):** 57.3
- **P/E (TTM):** 57.26
- **EPS (TTM):** ₹6.73
- **Book Value:** ₹159.17
- **Price to Book:** 2.37
- **Dividend Yield:** 0%
- **ROE:** 21.36%
- **ROCE:** 21.41%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹641.29 Cr
- **Net Income:** ₹35.92 Cr
- **EBITDA:** ₹34.09 Cr
- **52-Week High:** ₹404
- **52-Week Low:** ₹87.15
- **RSI (14):** 67.31

## Tapetide Score

- **Score:** 46 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 31.9 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 84.28 | 9% |
| growth | 98.9 | 9% |
| momentum | 98.9 | 12% |
| ownership | 40.45 | 24% |
| quality | 19.09 | 22% |
| valuation | 37.54 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -6.37% over past five years.
- Company has a low return on equity of 6.11% over last 3 years.
- Earnings include an other income of Rs.44.1 Cr.
- Debtor days have increased from 89.4 to 113 days.
- Working capital days have increased from 94.1 days to 165 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 84.39% | -113.09% | -118.87% |
| ebitda margin growth | 131.82% | -48.65% | -78.09% | -77.59% |
| net income growth | 63.58% | -85.66% | -7% | 78% |
| revenue growth | 15.76% | -0.28% | -19% | -6% |
| roce | 249.11% | -68.07% | 74.07% | 23.2% |
| roe | 63.23% | -52.8% | 24.54% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 290 | 288 | 529 | 33 | 12 | 129 | 138 | 153 | 153 | 151 | 170 | 191 |
| Expenses | 224 | 236 | 437 | 43 | 24 | 135 | 147 | 149 | 151 | 147 | 149 | 158 |
| Operating Profit | 66 | 52 | 91 | -10 | -12 | -7 | -9 | 4 | 1 | 4 | 21 | 33 |
| OPM % | 23 | 18 | 17 | -29 | -99 | -5 | -7 | 2.4 | 1 | 2.8 | 12 | 17 |
| Other Income | 7 | 7 | 458 | 11 | 13 | 16 | 220 | 15 | 18 | 22 | -3 | 7 |
| Interest | 21 | 21 | 3 | 0 | 0 | 10 | -27 | 1 | 2 | 1 | -2 | 1 |
| Depreciation | 13 | 14 | 20 | 0 | 0 | 6 | 7 | 7 | 7 | 9 | 8 | 8 |
| Profit before tax | 39 | 24 | 527 | 1 | 1 | -7 | 230 | 10 | 10 | 16 | 12 | 33 |
| Tax % | 18 | 19 | 6 | -3 | 31 | -16 | 4 | 17 | 22 | 42 | -26 | 25 |
| Net Profit | 32 | 19 | 494 | 1 | 0 | -5 | 222 | 9 | 8 | 10 | 15 | 25 |
| EPS in Rs | 5.36 | 3.29 | 83.55 | 0.16 | 0.07 | -0.93 | 36.67 | 1.45 | 0.98 | 1.17 | 1.74 | 2.84 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 765 | 757 | 780 | 891 | 1039 | 1207 | 1281 | 562 | 641 | 665 |
| Expenses | 631 | 630 | 635 | 709 | 837 | 978 | 1029 | 581 | 596 | 605 |
| Operating Profit | 134 | 126 | 144 | 183 | 202 | 229 | 252 | -19 | 45 | 60 |
| OPM % | 18 | 17 | 19 | 21 | 19 | 19 | 20 | -3.5 | 7 | 9 |
| Other Income | 16 | 120 | 33 | 23 | 37 | 7 | 434 | 305 | 36 | 44 |
| Interest | 28 | 92 | 107 | 100 | 96 | 92 | 51 | 3 | 1 | 1 |
| Depreciation | 87 | 104 | 90 | 87 | 131 | 57 | 53 | 24 | 31 | 32 |
| Profit before tax | 36 | 50 | -20 | 18 | 13 | 87 | 582 | 258 | 49 | 71 |
| Tax % | 39 | 42 | 7 | 117 | 117 | 45 | 28 | 3 | 16 | — |
| Net Profit | 22 | 29 | -21 | -3 | -2 | 48 | 421 | 250 | 41 | 57 |
| EPS in Rs | 4.85 | 6.09 | -3.59 | -0.53 | -0.36 | 8.06 | 71.24 | 41.32 | 4.77 | 6.73 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 45 | 46 | 48 | 60 | 60 | 60 | 60 | 59 | 69 | 87 |
| Reserves | 486 | 507 | 540 | 581 | 544 | 541 | 622 | 872 | 1104 | 1297 |
| Borrowings | 1242 | 1083 | 1148 | 1031 | 1005 | 953 | 862 | 17 | 41 | 18 |
| Other Liabilities | 364 | 387 | 188 | 198 | 210 | 247 | 280 | 217 | 224 | 271 |
| Total Liabilities | 2138 | 2023 | 1924 | 1870 | 1818 | 1801 | 1824 | 1165 | 1438 | 1673 |
| Fixed Assets | 1042 | 934 | 914 | 843 | 753 | 630 | 587 | 8 | 273 | 306 |
| CWIP | 70 | 69 | 20 | 11 | 19 | 10 | 8 | 0 | 0 | 10 |
| Investments | 18 | 18 | 19 | 17 | 36 | 29 | 30 | 111 | 213 | 248 |
| Other Assets | 1007 | 1002 | 972 | 998 | 1011 | 1131 | 1199 | 1047 | 952 | 1110 |
| Total Assets | 2138 | 2023 | 1924 | 1870 | 1818 | 1801 | 1824 | 1165 | 1438 | 1673 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 96 | 73 | -64 | 125 | 135 | 150 | 195 | -163 | -25 | -70 |
| Cash from Investing Activity | -31 | -17 | -12 | -9 | -10 | 5 | -13 | -104 | -110 | -73 |
| Cash from Financing Activity | -69 | -62 | 100 | -133 | -124 | -141 | -186 | 699 | 69 | 142 |
| Net Cash Flow | -4 | -6 | 23 | -17 | 1 | 14 | -4 | 431 | -66 | -1 |
| Free Cash Flow | 63 | 52 | -79 | 114 | 131 | 137 | 182 | -205 | -51 | -156 |
| CFO/OP | 90 | 54 | -51 | 87 | 73 | 74 | 85 | -65 | 131 | -140 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 182 | 194 | 169 | 186 | 177 | 160 | 153 | 48 | 107 | 113 |
| Inventory Days | 305 | 291 | 284 | 313 | 301 | 288 | 242 | 6 | 145 | 191 |
| Days Payable | 91 | 118 | 114 | 123 | 111 | 118 | 113 | 52 | 140 | 188 |
| Cash Conversion Cycle | 396 | 367 | 339 | 375 | 367 | 330 | 282 | 2 | 112 | 116 |
| Working Capital Days | -97 | -49 | 217 | 248 | 253 | 253 | 234 | 2 | 115 | 165 |
| ROCE % | 2 | 4 | 4 | 5 | 7 | 7 | 13 | 20 | 1 | 5 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 42% | 42% | 42% | 42% | 42% | 42% | 40.94% | 40.94% | 39.5% | 39.5% | 42.99% | 42.93% |
| FIIs | 0.17% | 0% | 0.25% | 1.26% | 0.65% | 0.46% | 3.07% | 4.27% | 14.8% | 14.33% | 13.88% | 10.7% |
| DIIs | 19.49% | 0% | 8.03% | 0.94% | 0.94% | 0.94% | 0.91% | 0.91% | 0.68% | 0.68% | 0% | 0.17% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 28.77% | 29.26% | 30.46% | 36.69% | 36.63% | 38.11% | 37.61% | 41.36% | 34.96% | 35.06% | 32.9% | 34.45% |
| Others | 9.56% | 28.73% | 19.26% | 19.11% | 19.78% | 18.49% | 17.46% | 12.51% | 10.06% | 10.43% | 10.22% | 11.75% |
| No. of Shareholders | 25405 | 24633 | 22439 | 25461 | 28883 | 28752 | 28190 | 28709 | 43780 | 42121 | 39222 | 40881 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 6 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 373.69 | Buy |
| EMA (10) | 372.08 | Buy |
| SMA (20) | 356.1 | Buy |
| EMA (20) | 350.99 | Buy |
| SMA (50) | 285.9 | Buy |
| EMA (50) | 297.61 | Buy |
| SMA (100) | 221.21 | Buy |
| EMA (100) | 246.03 | Buy |
| SMA (200) | 169.9 | Buy |
| EMA (200) | 195.78 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 69.18 | Neutral |
| MACD (12,26,9) | 29.71 | Sell |
| Stochastic (14,3,3) | 76.59 | Neutral |
| ADX (14) | 59.06 | Buy |
| Williams %R (14) | -22.22 | Neutral |
| ATR (14) | 19.53 | High Volatility |
| ROC (12) | 4.86 | Buy |
| Stoch RSI (14) | 29.34 | Neutral |
| UO (7,14,28) | 53.01 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e59de28-bac0-4106-93a9-61ee4e915b5b.pdf) |
| 2026-09-05 | [Notice Of 31St Annual General Meeting Scheduled To Be Held On Sept. 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e6d24b6-ab38-48b7-a12f-9828489b1f2e.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1030038a-682c-455c-9ee3-7f2c273fa639.pdf) |
| 2026-09-04 | [Outcome Of Preferential Issue Committee Meeting Held On Friday 4Th September 2026 As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c1377f3-a1c3-42bd-9b87-23f334ed9fce.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ae8fd75-7891-42a2-b55b-0537ec963b8a.pdf) |
| 2026-09-02 | [Board Meeting Outcome for Outcome Of Board Meeting Held On September 02 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d624a9e1-ed73-49de-b583-53a2a93cc5f4.pdf) |
| 2026-08-27 | [Clarification On Movement In Volume](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1eaeada2-a803-43a6-86dd-306d26506798.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=475b040d-7090-40dc-8696-5b161e3d5a38.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e2939f6-7af7-49e5-a233-a2432a38140a.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e132c39c-a847-4873-927e-a4ffc5bd6826.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Arbitration with PI Industries ended; all claims rejected on 7 April 2026, with nil financial impact. | [Clarification On Spurt In Volume 9 Apr - Arbitration with PI Industries ended; all claims rejected on 7 April 2026, with nil financial impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ad619b5-b36a-4f6b-bcae-57410961c345.pdf) |
| 8h - Postal ballot to approve MD appointments and high pay (Rs30–60L/month) effective Feb 1, 2026. | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 8h - Postal ballot to approve MD appointments and high pay (Rs30–60L/month) effective Feb 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c5bff184-0fbc-47ba-a680-b586776568ed.pdf) |
| 8h - Board appointed M/s. Jain & Associates as internal auditors for FY2026-27; approved postal ballot notice; meeting 27-Mar-2026. | [Board Meeting Outcome for Outcome Of Board Meeting Held On March 27, 2026 8h - Board appointed M/s. Jain & Associates as internal auditors for FY2026-27; approved postal ballot notice; meeting 27-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/93044a09-ddba-4c61-8483-df73b8338e5c.pdf) |
| 7 Apr - PI Industries arbitration award rejected all claims; proceedings concluded with nil financial impact. | [Intimation Of Receipt Of Arbitration Award 7 Apr - PI Industries arbitration award rejected all claims; proceedings concluded with nil financial impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/82f382c5-097c-4464-a567-e9b079c4167e.pdf) |
| 6 Apr - Newspaper clippings- Special Window for re-lodgement of transfer requests of physical shares and dematerialisation | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Apr - Newspaper clippings- Special Window for re-lodgement of transfer requests of physical shares and dematerialisation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08476890-a83b-4539-81ca-fa5560f27fed.pdf) |
| 5 May - Postal ballot passed four special resolutions appointing MDs and approving remuneration on 5 May 2026. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 5 May - Postal ballot passed four special resolutions appointing MDs and approving remuneration on 5 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/02d09ed5-8699-40bc-8919-e6ba35c3e215.pdf) |
| 31 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for quarter/FY ended 31 March 2026. | [Closure of Trading Window 31 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for quarter/FY ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a859ce62-7467-406c-993a-47de147e533a.pdf) |
| 31 Mar - Of allotment of 1,25,000 shares pursuant to ESOP 2014 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 31 Mar - Of allotment of 1,25,000 shares pursuant to ESOP 2014](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f983e909-4d7f-430e-be06-7eb678dc045f.pdf) |
| 3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/469d7022-a9a2-4a93-8931-c8e4c9adf83c.pdf) |
| 27 Feb - Essix converted 5,100,000 warrants to equity on Feb 24, 2026; promoter holding rises to 43.06%. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 27 Feb - Essix converted 5,100,000 warrants to equity on Feb 24, 2026; promoter holding rises to 43.06%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/427eb23f-d7a6-4389-af68-69853409a49c.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20e51151-92d1-4584-b075-38946d071365.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53bc6695-3b3b-4d54-9e49-fd338cb7b144.pdf) |
| 2026-02-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b38c0cc9-6ef5-4074-a68b-0d45a9dfcee5.pdf) |
| 2026-01-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1aea0d8d-53f1-4c67-9417-9110bc29ff21.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-17 | [Audio Recording Of Earning Conference Call Held On 17.08.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e429ed4e-3f01-4185-b312-a019bc44165c.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11a9dffb-9321-4555-a46c-3851033b9a30.pdf) |
| 2026-05-28 | [Audited Financial Results For The Quarter And Financial Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c81164f-6bd7-4814-b20b-38acba628472.pdf) |
| 2026-01-31 | [Financial Results For The Quarter Ended December 31 2025 On Standalone And Consolidated Basis.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0786fff1-14de-4895-99a5-f903a9fe5de7.pdf) |
| 2025-08-13 | [Standalone And Consolidated Un-Audited Financial Results Of Ind-Swift Laboratories Limited For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c92d2ee-e14d-4218-803a-306662f0e34d.pdf) |
| 2025-08-11 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3d42e23-acd5-49c1-99a3-917b7849b215.pdf) |
| 2025-02-13 | [Financial Results For The Quarter And Nine Months Ended 31/12/2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=998c3128-55e3-46fc-a436-9b5b2155b95c.pdf) |
| 2024-11-11 | [Financial Results For The Quarter And Half Year Ended 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=931d320d-edfc-46d4-8150-b07d170d72b2.pdf) |
| 2024-08-12 | [Financial Results For Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2205a617-6c98-4b17-91f9-631309cca9a0.pdf) |
| 2024-05-13 | [Financial Results For The Year Ended On 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3a092c2-de04-44c5-a40e-6bfdf736875a.pdf) |
| 2024-02-12 | [Results- Financial Results For The Quarter Ended December 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39b7a990-ec96-4362-ad7d-a4faea77d95e.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43b9a794-56b9-4a7f-bb2e-c501cd49879f.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43b9a794-56b9-4a7f-bb2e-c501cd49879f.pdf) |
| Jul 2020 | [Concall - Jul 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=715cd916-569d-434c-8c3c-f7d129dc5604.pdf) |
| Jul 2020 | [Concall - Jul 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/715cd916-569d-434c-8c3c-f7d129dc5604.pdf) |
| Jan 2026 | [Concall - Jan 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1aea0d8d-53f1-4c67-9417-9110bc29ff21.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b38c0cc9-6ef5-4074-a68b-0d45a9dfcee5.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_INDSWFTLAB_2011_2012_14092012091245.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/00dc7b70-03cb-4573-99ed-0b3e05ebf276.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/255c9918-ec21-425b-9dbb-88eaf0bd13a1.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5f20d87d-3055-4c3f-86fe-2dfca3b16f6d.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532305/76414532305.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532305/71795532305.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532305/66579532305.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532305/5323050319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/532305/5323050318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/532305/5323050317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:56:26.657Z.